Sinopep Allsino Bio Pharmaceutical Co Ltd - Class A

SHSE:688076 (China)   Class A
Â¥ 54.77 (-0.54%) Apr 29
72.07
P/B:
5.38
Market Cap:
Â¥ 11.68B ($ 1.61B)
Enterprise V:
Â¥ 12.05B ($ 1.66B)
Volume:
281.56M
Avg Vol (2M):
3.81M
Volume:
281.56M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Sinopep Allsino Bio Pharmaceutical Co Ltd ( ) from 2021 to Apr 29 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Sinopep Allsino Bio Pharmaceutical stock (SHSE:688076) PE ratio as of Apr 29 2024 is 72.07. More Details

Sinopep Allsino Bio Pharmaceutical Co Ltd (SHSE:688076) PE Ratio (TTM) Chart

To

Sinopep Allsino Bio Pharmaceutical Co Ltd (SHSE:688076) PE Ratio (TTM) Historical Data

Total 715
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 8
Sinopep Allsino Bio Pharmaceutical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-29 72.1 2024-02-22 61.7
2024-04-26 72.5 2024-02-21 62.1
2024-04-25 72.0 2024-02-20 63.7
2024-04-24 71.1 2024-02-19 60.5
2024-04-23 72.7 2024-02-08 57.6
2024-04-22 70.6 2024-02-07 56.7
2024-04-19 67.3 2024-02-06 54.7
2024-04-18 67.8 2024-02-05 50.8
2024-04-17 68.0 2024-02-02 54.9
2024-04-16 67.1 2024-02-01 55.7
2024-04-15 68.1 2024-01-31 53.5
2024-04-12 68.4 2024-01-30 52.8
2024-04-11 66.0 2024-01-29 53.4
2024-04-10 67.8 2024-01-26 52.4
2024-04-09 70.5 2024-01-25 54.4
2024-04-08 72.3 2024-01-24 51.8
2024-04-03 70.4 2024-01-23 50.8
2024-04-02 70.1 2024-01-22 50.7
2024-04-01 69.5 2024-01-19 54.2
2024-03-29 69.5 2024-01-18 56.3
2024-03-28 73.0 2024-01-17 57.2
2024-03-27 74.1 2024-01-16 59.1
2024-03-26 77.0 2024-01-15 58.0
2024-03-25 75.5 2024-01-12 58.0
2024-03-22 75.2 2024-01-11 58.5
2024-03-21 74.7 2024-01-10 54.8
2024-03-20 75.6 2024-01-09 56.4
2024-03-19 73.7 2024-01-08 54.8
2024-03-18 72.8 2024-01-05 57.1
2024-03-15 72.2 2024-01-04 59.3
2024-03-14 72.1 2024-01-03 57.9
2024-03-13 71.5 2024-01-02 58.6
2024-03-12 69.6 2023-12-29 59.1
2024-03-11 69.9 2023-12-28 56.9
2024-03-08 67.2 2023-12-27 53.8
2024-03-07 66.5 2023-12-26 53.5
2024-03-06 68.7 2023-12-25 54.5
2024-03-05 69.7 2023-12-22 54.8
2024-03-04 69.5 2023-12-21 54.2
2024-03-01 66.1 2023-12-20 54.0
2024-02-29 66.6 2023-12-19 54.4
2024-02-28 64.2 2023-12-18 51.8
2024-02-27 64.2 2023-12-15 51.2
2024-02-26 62.3 2023-12-14 52.0
2024-02-23 62.4 2023-12-13 53.7

Sinopep Allsino Bio Pharmaceutical Co Ltd (SHSE:688076) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Sinopep Allsino Bio Pharmaceutical Co Ltd is a market-oriented, research and development and innovation-driven biomedical enterprise focusing on the research, development, production and sales of peptide drugs and small molecule chemical drugs.